Skip to main content
BIOX
NASDAQ Life Sciences

Bioceres Returns to Positive Adjusted EBITDA in Q4, But Full-Year Loss Widens

Tom Rudovsky · Reported by BusinessWire
More coverage: Industrial
Sentiment info
Negative
Importance info
7
Price
$0.434
Mkt Cap
$27.074M
52W Low
$0.301
52W High
$2.19
52W Position info
44% above low
Off High info
80% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BIOX sits 44% above its 52-week low of $0.301.

Summary

Bioceres reported fiscal Q4 revenue of $55.9M, roughly flat YoY, with a net loss from continuing operations of $31.8M, an improvement from $54.4M a year ago. Adjusted EBITDA turned positive at $0.6M versus negative $9.6M in Q4 2025, driven by a 19% cut in SG&A. For the full year, revenue fell 18% to $238.3M and net loss widened to $54.4M from $49.1M, while Adjusted EBITDA declined to $25.5M from $28.9M. The company also recorded a $179.4M loss from discontinued operations related to the Pro Farm Group foreclosure. Management highlighted cost reductions and a strategic roadmap, but the balance sheet shows cash down to $11.2M from $32.7M and total equity collapsed to $64.1M from $295.2M. The earnings call is scheduled for September 15, 2026.

At the time of this announcement, BIOX was trading at $0.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $27.1M. The 52-week trading range was $0.30 to $2.19. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

BIOX - Latest Insights

BIOX
Nov 11, 2026, 5:51 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.2327
Real-time Price: $0.210 info
Change: -$0.0227 (-10%) info
Market Cap: $12.827M info
BIOX
Oct 30, 2026, 5:04 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.208
Real-time Price: $0.210 info
Change: +$0.0020 (+0.96%) info
Market Cap: $12.827M info
BIOX
Sep 21, 2026, 6:09 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.346
Real-time Price: $0.210 info
Change: -$0.136 (-39%) info
Market Cap: $12.827M info
BIOX
Sep 15, 2026, 7:04 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.392
Real-time Price: $0.210 info
Change: -$0.182 (-46%) info
Market Cap: $12.827M info
BIOX
Jul 07, 2026, 7:08 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.3294
Real-time Price: $0.210 info
Change: -$0.1194 (-36%) info
Market Cap: $12.827M info